CN1635165A - 一种基于生物芯片检测核酸结合蛋白的方法 - Google Patents
一种基于生物芯片检测核酸结合蛋白的方法 Download PDFInfo
- Publication number
- CN1635165A CN1635165A CN200410090423.3A CN200410090423A CN1635165A CN 1635165 A CN1635165 A CN 1635165A CN 200410090423 A CN200410090423 A CN 200410090423A CN 1635165 A CN1635165 A CN 1635165A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- nucleic acids
- probe
- sequence
- acids probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 127
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 99
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 99
- 238000000034 method Methods 0.000 title claims abstract description 68
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 47
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 39
- 238000000018 DNA microarray Methods 0.000 title claims abstract description 18
- 239000000523 sample Substances 0.000 claims abstract description 175
- 238000009396 hybridization Methods 0.000 claims abstract description 34
- 230000000295 complement effect Effects 0.000 claims abstract description 4
- 108091023040 Transcription factor Proteins 0.000 claims description 42
- 102000040945 Transcription factor Human genes 0.000 claims description 42
- 102000044158 nucleic acid binding protein Human genes 0.000 claims description 35
- 108700020942 nucleic acid binding protein Proteins 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 27
- 108091008324 binding proteins Proteins 0.000 claims description 23
- 108020004414 DNA Proteins 0.000 claims description 15
- 230000027455 binding Effects 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 15
- 102000053602 DNA Human genes 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 238000011084 recovery Methods 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 229930003756 Vitamin B7 Natural products 0.000 claims description 9
- 239000011735 vitamin B7 Substances 0.000 claims description 9
- 235000011912 vitamin B7 Nutrition 0.000 claims description 9
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 8
- 239000010931 gold Substances 0.000 claims description 8
- 229910052737 gold Inorganic materials 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- 239000002096 quantum dot Substances 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 5
- 102000044126 RNA-Binding Proteins Human genes 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 4
- 239000003446 ligand Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 3
- 101710116602 DNA-Binding protein G5P Proteins 0.000 claims description 3
- 101710162453 Replication factor A Proteins 0.000 claims description 3
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 claims description 3
- 101710176276 SSB protein Proteins 0.000 claims description 3
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims description 3
- 101710159080 Aconitate hydratase A Proteins 0.000 claims description 2
- 101710159078 Aconitate hydratase B Proteins 0.000 claims description 2
- 101710105008 RNA-binding protein Proteins 0.000 claims description 2
- 238000011091 antibody purification Methods 0.000 claims description 2
- 239000012472 biological sample Substances 0.000 claims description 2
- 238000005251 capillar electrophoresis Methods 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 238000001502 gel electrophoresis Methods 0.000 claims description 2
- 102000023732 binding proteins Human genes 0.000 claims 12
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims 5
- 239000000126 substance Substances 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000002331 protein detection Methods 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 description 17
- 238000002372 labelling Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 102000014914 Carrier Proteins Human genes 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 230000002860 competitive effect Effects 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 102100023132 Transcription factor Jun Human genes 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 5
- 239000013256 coordination polymer Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010018242 Transcription Factor AP-1 Proteins 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108020003215 DNA Probes Proteins 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 102000004586 YY1 Transcription Factor Human genes 0.000 description 3
- 108010042669 YY1 Transcription Factor Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000022131 cell cycle Effects 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 101150092780 GSP1 gene Proteins 0.000 description 2
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 2
- 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 102000006290 Transcription Factor TFIID Human genes 0.000 description 2
- 108010083268 Transcription Factor TFIID Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 108091000371 single-stranded RNA binding proteins Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 102000016662 ELAV Proteins Human genes 0.000 description 1
- 108010053101 ELAV Proteins Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 102100023008 Single-stranded DNA-binding protein 3 Human genes 0.000 description 1
- 101710141937 Single-stranded DNA-binding protein 3 Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000004637 cellular stress Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000002337 electrophoretic mobility shift assay Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组编号 | 转录因子 | 探针编号 | 探针名称 | 探针序列 |
1 | AP-1 | 1 | AP-1-IP | 5′-T20-CGCTTGA TGAGTCAGCCGGA-TCCCG-3′ |
2 | AP-1-LP | 5′-biotin-CGGGA-TCCGGC TGACTCATCAAGCG-3′ | ||
3 | AP-1-FP | 5′-CGCTTGA TGAGTCAGCCGGA-3′ |
4 | AP-1-CP | 5′-TCCGGC TGACTCATCAAGCG-3′ | ||
2 | NFκB | 5 | NFκB-IP | 5′-T20-AGTTGAG GGGACTTTCCCAGGA-TCCCG-3′ |
6 | NFκB-LP | 5′-biotin-CGGGA-TCCTG GGAAAGTCCCCTCAACT-3′ | ||
7 | NFκB-FP | 5′-AGTTGAG GGGACTTTCCCAGGA-3′ | ||
8 | NFκB-CP | 5′-TCCTG GGAAAGTCCCCTCAACT-3′ | ||
3 | SP1 | 9 | SP1-IP | 5′-T20-AAAGC CCCGCCCCGATATAAT-TCCCG-3′ |
10 | SP1-LP | 5′-biotin-CGGGA-ATTATATC GGGGCGGGGCTTT-3′ | ||
11 | SP1-FP | 5′-AAAGC CCCGCCCCGATATAAT-3′ | ||
12 | SP1-CP | 5′-ATTATATC GGGGCGGGGCTTT-3′ | ||
4 | TFIID | 13 | TFIID-IP | 5′-T20-CGCCTACCTCATT TTATATGCTCTGC-TCCCG3′ |
14 | TFIID-LP | 5′-biotin-CGGGA-GCAGAGCA TATAAAATGAGGTAGGCG-3′ | ||
15 | TFIID-FP | 5′-CGCCTACCTCATT TTATATGCTCTGC-3′ | ||
16 | TFIID-CP | 5′-GCAGAGCA TATAAAATGAGGTAGGCG-3′ | ||
5 | NC | 17 | NC-IP | 5′-T20-CTATGTGGTGAACTCCTCCTAAATA-TCCCG-3′ |
18 | NC-LP | 5′-biotin-CGGGA-CGGGATATTTAGGAGGAGTTCACCACATAG-3′ | ||
19 | NC-FP | 5′-CTATGTGGTGAACTCCTCCTAAATA-3′ | ||
6 | HC | 20 | HC-IP | 5′-T20-AGACGGAAGACATATGGCCGCTC-TCCCG-3′ |
21 | HC-LP | 5′-biotin-CGGGA-GAGCGGCCATATGTCTTCCGTCT-3′ |
组编号 | TF | 探针编号 | 探针名称 | 探针序列 |
1 | AP-1 | 1 | AP-1-IP | 5′-T20-CGCT TGATGAGTCAGCCGGA-TCCCG-3′ |
22 | AP-1-LFP | 5′-CGCTTGA TGAGTCAGCCGGA-CCCTATAGTGAGTCGTATTACCCC-3′ | ||
26 | AP-1-LP’ | 5′-CGGGA-TCCGGC TGACTCATCAAGCG-3′ | ||
2 | NFκB | 5 | NFκB-IP | 5′-T20-AGTTGAG GGGACTTTCCCAGGA-TCCCG-3′ |
23 | NFκB-LFP | 5′-AGTTGAG GGGACTTTCCCAGGA-CCCTATAGTGAGTCGTATTACCCC-3′ | ||
27 | NFκB-LP’ | 5′-CGGGA-TCCTG GGAAAGTCCCCTCAACT-3′ | ||
3 | SP1 | 9 | SP1-IP | 5′-T20-AAAGC CCCGCCCCGATATAAT-TCCCG-3′ |
24 | SP1-LFP | 5′-AAAGC CCCGCCCCGATATAAT-CCCTATAGTGAGTCGTATTACCCC-3′ | ||
28 | SP1-LP’ | 5′-CGGGA-ATTATATC GGGGCGGGGCTTT-3′ | ||
4 | 25 | T7 Pro | 5’-Cy3-GGGGTAATACGACTCACTATAGGG-3’ |
Claims (27)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100904233A CN1296492C (zh) | 2004-11-18 | 2004-11-18 | 一种基于生物芯片检测能结合特异序列的核酸结合蛋白的方法 |
AU2004324960A AU2004324960A1 (en) | 2004-11-18 | 2004-11-23 | A testing method of nucleic acid binding protein based on biochip |
EP04797371A EP1816476B1 (en) | 2004-11-18 | 2004-11-23 | A testing method of nucleic acid binding protein based on biochip |
CA002586408A CA2586408A1 (en) | 2004-11-18 | 2004-11-23 | A testing method of nucleic acid binding protein based on biochip |
US11/791,157 US8680016B2 (en) | 2004-11-18 | 2004-11-23 | Testing method of nucleic acid binding protein based on biochip |
JP2007541638A JP4664373B2 (ja) | 2004-11-18 | 2004-11-23 | バイオチップをベースにした核酸結合タンパク質の試験方法 |
PCT/CN2004/001340 WO2006053463A1 (fr) | 2004-11-18 | 2004-11-23 | Procede de test de proteine de liaison aux acides nucleiques |
AT04797371T ATE545030T1 (de) | 2004-11-18 | 2004-11-23 | Testverfahren für nukleinsäurebindendes protein auf biochipbasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100904233A CN1296492C (zh) | 2004-11-18 | 2004-11-18 | 一种基于生物芯片检测能结合特异序列的核酸结合蛋白的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1635165A true CN1635165A (zh) | 2005-07-06 |
CN1296492C CN1296492C (zh) | 2007-01-24 |
Family
ID=34847597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100904233A Expired - Fee Related CN1296492C (zh) | 2004-11-18 | 2004-11-18 | 一种基于生物芯片检测能结合特异序列的核酸结合蛋白的方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8680016B2 (zh) |
EP (1) | EP1816476B1 (zh) |
JP (1) | JP4664373B2 (zh) |
CN (1) | CN1296492C (zh) |
AT (1) | ATE545030T1 (zh) |
AU (1) | AU2004324960A1 (zh) |
CA (1) | CA2586408A1 (zh) |
WO (1) | WO2006053463A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102112626A (zh) * | 2008-04-09 | 2011-06-29 | 加州理工学院 | 用于检测和/或分类靶标的捕获剂以及相关方法和系统 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8394590B2 (en) | 2006-08-02 | 2013-03-12 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
WO2008016680A1 (en) | 2006-08-02 | 2008-02-07 | California Institute Of Technology | Methods and systems for detecting and/or sorting targets |
AU2008276027B2 (en) | 2007-07-16 | 2014-09-04 | California Institute Of Technology | Arrays, substrates, devices, methods and systems for detecting target molecules |
KR101090982B1 (ko) | 2009-03-16 | 2011-12-08 | 경희대학교 산학협력단 | 양자점-앱타머 접합체를 이용한 생분석 방법 |
JP2012524907A (ja) * | 2009-04-24 | 2012-10-18 | ディスカヴァーエックス コーポレイション | 検出可能なタンパク質を用いた細胞分析 |
LT2783216T (lt) | 2011-11-21 | 2019-01-25 | Abaxis, Inc. | Imunoanalizė su signalo sustiprinimu |
CN103048463A (zh) * | 2012-05-02 | 2013-04-17 | 中国科学院广州生物医药与健康研究院 | 一种基于不同严谨度的用于检测dna结合蛋白的微孔板核酸杂交elisa方法 |
WO2014031997A1 (en) | 2012-08-24 | 2014-02-27 | Yale University | System, device and method for high-throughput multi-plexed detection |
WO2015060511A1 (ko) * | 2013-10-22 | 2015-04-30 | 주식회사 바이오이즈 | 생체분자와 핵산의 결합정보를 생성하기 위한 마커, 이의 제조방법, 이를 이용한 생체분자 분석방법 및 장치 |
TWI691716B (zh) | 2014-08-13 | 2020-04-21 | 美商艾巴希斯公司 | 電漿特異性結合搭配物檢定中之信號放大 |
CN107407638B (zh) | 2014-12-03 | 2021-01-12 | 伊索普莱西斯公司 | 细胞分泌特征的分析和筛选 |
US11353448B2 (en) | 2015-02-13 | 2022-06-07 | California Institute Of Technology | Methods and compositions for quantifying metabolites and proteins from single cells |
CN117434261A (zh) | 2015-08-04 | 2024-01-23 | 硕腾服务有限责任公司 | 基于溶液的等离子体特异性结合配偶体测定中的信号放大 |
DK3538891T3 (da) | 2016-11-11 | 2022-03-28 | Isoplexis Corp | Sammensætninger og fremgangsmåder til samtidig genomisk, transkriptomisk og proteomisk analyse af enkeltceller |
CN110226084A (zh) | 2016-11-22 | 2019-09-10 | 伊索普莱克西斯公司 | 用于细胞捕获的系统、装置和方法,以及其制造方法 |
AU2018212009B2 (en) | 2017-01-30 | 2022-07-14 | Zoetis Services Llc | Solution-based plasmon specific-binding partner assays and metallic nanostructures |
CA3138367A1 (en) * | 2019-04-30 | 2020-11-05 | Encodia, Inc. | Methods for preparing analytes and related kits |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449603A (en) * | 1989-10-24 | 1995-09-12 | Stratagene | Method for hybridizing nucleic acids using single-stranded nucleic acid binding protein |
DE69334048D1 (de) * | 1992-01-28 | 2006-08-31 | Harvard College | Verfahren fur nuklein saure hibridisierung mit verwendung von einzelstrangige dna bindende proteine |
US20030054378A1 (en) * | 1997-05-08 | 2003-03-20 | Isao Karube | Method for detecting target nucleotide sequence |
US20030207295A1 (en) * | 1999-04-20 | 2003-11-06 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US20060292560A1 (en) * | 2000-08-14 | 2006-12-28 | Robert Burgess | Transcription factor target gene discovery |
CA2327561A1 (en) | 2000-12-27 | 2002-06-27 | Pierre Rousseau | Methods for the screening and/or for the identification of differentially active nucleic acid binding factors of nucleic acid binding elements using dna microarray technology (dpa):dna proteomic array |
JP2004537039A (ja) * | 2001-03-30 | 2004-12-09 | クローンテック ラボラトリーズ インク. | 試料中の多数のdna結合タンパク質およびdna相互作用を検出する方法並びにこれを実施するための装置、システムおよびキット |
AU2002305585A1 (en) * | 2001-04-23 | 2002-11-05 | Michael F. Chou | Transcription factor network discovery methods |
US20030219801A1 (en) * | 2002-03-06 | 2003-11-27 | Affymetrix, Inc. | Aptamer base technique for ligand identification |
AU2003256814A1 (en) | 2002-07-26 | 2004-02-16 | Alfa Wasserman, Inc. | Macromolecular protection assay |
US20060166206A1 (en) * | 2002-11-15 | 2006-07-27 | Sangamo Biosciences, Inc. | Methods and compositions for analysis of regulatory sequences |
US20040115794A1 (en) | 2002-12-12 | 2004-06-17 | Affymetrix, Inc. | Methods for detecting transcriptional factor binding sites |
CN1435492A (zh) * | 2003-03-05 | 2003-08-13 | 东南大学 | 一种非标记检测dna结合蛋白的芯片及其制备、应用方法 |
JP3944576B2 (ja) * | 2003-03-28 | 2007-07-11 | 独立行政法人産業技術総合研究所 | マイクロアレイを用いたアプタマーの取得方法 |
-
2004
- 2004-11-18 CN CNB2004100904233A patent/CN1296492C/zh not_active Expired - Fee Related
- 2004-11-23 AT AT04797371T patent/ATE545030T1/de active
- 2004-11-23 EP EP04797371A patent/EP1816476B1/en not_active Not-in-force
- 2004-11-23 CA CA002586408A patent/CA2586408A1/en not_active Abandoned
- 2004-11-23 AU AU2004324960A patent/AU2004324960A1/en not_active Abandoned
- 2004-11-23 US US11/791,157 patent/US8680016B2/en not_active Expired - Fee Related
- 2004-11-23 WO PCT/CN2004/001340 patent/WO2006053463A1/zh active Application Filing
- 2004-11-23 JP JP2007541638A patent/JP4664373B2/ja not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102112626A (zh) * | 2008-04-09 | 2011-06-29 | 加州理工学院 | 用于检测和/或分类靶标的捕获剂以及相关方法和系统 |
Also Published As
Publication number | Publication date |
---|---|
EP1816476B1 (en) | 2012-02-08 |
JP2008520212A (ja) | 2008-06-19 |
US20090018025A1 (en) | 2009-01-15 |
ATE545030T1 (de) | 2012-02-15 |
US8680016B2 (en) | 2014-03-25 |
AU2004324960A1 (en) | 2006-05-26 |
JP4664373B2 (ja) | 2011-04-06 |
EP1816476A1 (en) | 2007-08-08 |
WO2006053463A1 (fr) | 2006-05-26 |
EP1816476A4 (en) | 2008-08-20 |
CA2586408A1 (en) | 2006-05-26 |
CN1296492C (zh) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1296492C (zh) | 一种基于生物芯片检测能结合特异序列的核酸结合蛋白的方法 | |
US7179638B2 (en) | Microarrays and their manufacture by slicing | |
US20050202433A1 (en) | Novel high density arrays and methods for analyte analysis | |
US20020015952A1 (en) | Microarrays and their manufacture by slicing | |
CN1500150A (zh) | 在固相载体上扩增和检测多个多核苷酸的方法 | |
JP2002500374A (ja) | 高分子アレイおよび結合アッセイにおけるそれらの使用のための方法 | |
JP2003014755A (ja) | マイクロアレイおよびその製造方法 | |
CN1522304A (zh) | 脓毒症或脓毒相关综合症生物芯片在诊断上的应用 | |
JP2008520212A5 (zh) | ||
EP3299474A1 (en) | Method and kit for detecting target nucleic acid | |
CN103003444B (zh) | 用于结肠直肠癌预后的方法和试剂盒 | |
EP1457573B1 (en) | Method for integrated nucleic acid integrity assessment and analysis | |
US20030211532A1 (en) | Methods and compositions for analyzing nucleic acids | |
CN113026111A (zh) | 用于构建人单细胞tcr测序文库的试剂盒及其应用 | |
CN1644709A (zh) | 一种用短串联重复序列位点等位基因阶梯的个体识别dna鉴定方法及其检测试剂盒 | |
CN1312293C (zh) | 一种高通量生物芯片及其应用 | |
US20220025430A1 (en) | Sequence based imaging | |
CN1590560A (zh) | 一种从复杂组分物质如中药和化学混合物中高通量筛选、捕获和分离目标分子的方法 | |
CN1721547A (zh) | 核酸外切酶ⅲ消化包被在微孔板上的含有特殊标记的双链核酸分子检测转录因子蛋白 | |
CN1470873A (zh) | Dna固相扩增与流式检测分析技术与试剂盒 | |
CN1597986A (zh) | 一种发卡结构探针的脱氧核糖核酸芯片及其应用方法 | |
WO2019229792A1 (ja) | 標的核酸断片を検出する方法 | |
CN1733933A (zh) | 核酸外切酶Ⅲ消化Label-dsDNA微阵列芯片检测转录因子蛋白 | |
Anderson | Microarrays and their manufacture by slicing | |
JP2008107227A (ja) | 物質間相互作用検出部とセンサーチップ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1079552 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CAPITALBIO CORPORATION CO., LTD. Free format text: FORMER NAME: CAPITALBIO CORPORATION |
|
CP01 | Change in the name or title of a patent holder |
Address after: 102206 Beijing City, Changping District Life Science Park Road No. 18 Patentee after: CAPITALBIO Corp. Patentee after: TSINGHUA University Address before: 102206 Beijing City, Changping District Life Science Park Road No. 18 Patentee before: CAPITALBIO Corp. Patentee before: Tsinghua University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070124 Termination date: 20211118 |
|
CF01 | Termination of patent right due to non-payment of annual fee |